Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
systemic scleroderma | FBN1* | Fbn1* | 3 models | Alliance of Genome Resources | |||
systemic scleroderma | COL3A1 | Col3a1* | 1 model | Alliance of Genome Resources | |||
systemic scleroderma | FLI1 | Fli1* | 1 model | Alliance of Genome Resources | |||
systemic scleroderma | FOSL2 | Fosl2* | 1 model | Alliance of Genome Resources | |||
systemic scleroderma | TGFBR1 | Tgfbr1* | 1 model | Alliance of Genome Resources | |||
diffuse scleroderma | TAP2* | Tap2 | Alliance of Genome Resources | ||||
diffuse scleroderma | STAT4* | Stat4 | Alliance of Genome Resources | ||||
diffuse scleroderma | TAP1* | Tap1 | Alliance of Genome Resources | ||||
diffuse scleroderma | BANK1* | Bank1 | Alliance of Genome Resources | ||||
diffuse scleroderma | CAV1* | Cav1 | Alliance of Genome Resources | ||||
diffuse scleroderma | FCGR2A*, FCGR2B, FCGR2C | Fcgr2b, Fcgr3 | Alliance of Genome Resources | ||||
diffuse scleroderma | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
diffuse scleroderma | IL13* | Il13 | Alliance of Genome Resources | ||||
diffuse scleroderma | IRAK1* | Irak1 | Alliance of Genome Resources | ||||
diffuse scleroderma | WRN* | Wrn | Alliance of Genome Resources | ||||
diffuse scleroderma | TLR2* | Tlr2 | Alliance of Genome Resources | ||||
disabling pansclerotic morphea | STAT4* | Stat4 | Alliance of Genome Resources | ||||
limited scleroderma | IL2* | Il2 | Alliance of Genome Resources | ||||
limited scleroderma | STAT4* | Stat4 | Alliance of Genome Resources | ||||
limited scleroderma | TAP2* | Tap2 | Alliance of Genome Resources | ||||
limited scleroderma | CAV1* | Cav1 | Alliance of Genome Resources | ||||
localized scleroderma | HGF* | Hgf | Alliance of Genome Resources | ||||
localized scleroderma | MMP1* | Mmp1a, Mmp1b | Alliance of Genome Resources | ||||
scleroderma | HLA-A*, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
systemic scleroderma | NAT2*, NAT1 | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
systemic scleroderma | NOTCH4* | Notch4 | Alliance of Genome Resources | ||||
systemic scleroderma | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
systemic scleroderma | SLC11A1* | Slc11a1 | Alliance of Genome Resources | ||||
systemic scleroderma | STAT4* | Stat4 | Alliance of Genome Resources | ||||
systemic scleroderma | ANXA5* | Anxa5 | Alliance of Genome Resources | ||||
systemic scleroderma | BANK1* | Bank1 | Alliance of Genome Resources | ||||
systemic scleroderma | CAV1* | Cav1 | Alliance of Genome Resources | ||||
systemic scleroderma | CD86* | Cd86 | Alliance of Genome Resources | ||||
systemic scleroderma | CX3CR1* | Cx3cr1 | Alliance of Genome Resources | ||||
systemic scleroderma | ELN* | Eln | Alliance of Genome Resources | ||||
systemic scleroderma | ESR1* | Esr1 | Alliance of Genome Resources | ||||
systemic scleroderma | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
systemic scleroderma | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
systemic scleroderma | HGF* | Hgf | Alliance of Genome Resources | ||||
systemic scleroderma | HNRNPL* | Hnrnpl | Alliance of Genome Resources | ||||
systemic scleroderma | IFNG* | Ifng | Alliance of Genome Resources | ||||
systemic scleroderma | IL1B* | Il1b | Alliance of Genome Resources | ||||
systemic scleroderma | IL1R1* | Il1r1 | Alliance of Genome Resources | ||||
systemic scleroderma | IL23R* | Il23r | Alliance of Genome Resources | ||||
systemic scleroderma | LTA* | Lta | Alliance of Genome Resources | ||||
systemic scleroderma | MMP3* | Mmp3 | Alliance of Genome Resources | ||||
systemic scleroderma | MMP9* | Mmp9 | Alliance of Genome Resources |
Transgenes and other genome features developed in mice to model this disease.
|
|||
Disease Term | Transgenes and Other Genome Features | Mouse Models | |
systemic scleroderma | Tg(H2-K-Fosl2,-EGFP)13Wag | 1 model |